This is all great for people with decent commercial insurance. My situation: small employer plan through UHC. They explicitly exclude ALL anti-obesity medications. No Wegovy, no Zepbound, no Contrave, nothing.

The Zepbound savings card without coverage path gives me $550/month. That's $6,600/year. I make $52K. That's almost 13% of my pre-tax income on one medication.

I ended up going the compounded semaglutide route through a telehealth provider. $149/month. Is it the same as brand? Probably not exactly. But it's working — down 34 lbs in 5 months — and I can actually afford it without choosing between medication and rent.

The system is broken when insurance happily covers the downstream costs of obesity (joint replacements, diabetes meds, cardiac interventions) but won't cover a preventive medication that costs a fraction of those interventions.

I completely agree about the system being broken. For what it's worth, some states are starting to mandate coverage. If you're in a state with pending legislation, it might be worth writing to your state rep.

Updated summary of all the paths discussed in this thread:

1. Best case: Commercial insurance coverage + savings card = ~$25/mo
2. Insurance covers but high copay: Savings card brings it down significantly
3. No insurance coverage: Manufacturer savings card = ~$500-550/mo
4. Between plans: Bridge programs for temporary free supply
5. Budget route: Compounded semaglutide via telehealth = ~$100-200/mo
6. Cash pay retail: $1,069-1,349/mo (avoid this if at all possible)